Tempest Therapeutics (TPST) Non-Current Assets (2012 - 2026)

Tempest Therapeutics has disclosed Non-Current Assets across 15 years of filings, most recently posting $7.9 million for Q2 2026.

• In Q2 2026, Non-Current Assets fell 15.4% year-over-year to $7.9 million; the TTM figure through Jun 2026 stood at $35.0 million (down 11.18% YoY), while the FY2025 annual figure was $8.7 million, down 13.5% from the prior year.
• Non-Current Assets came in at $7.9 million for Q2 2026 at Tempest Therapeutics, down from $8.7 million in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $13.1 million in Q4 2022 to a low of $2.9 million in Q3 2022.
• Average Non-Current Assets over 5 years is $9.3 million, with a median of $10.0 million recorded in 2024.
• Year-over-year, Non-Current Assets tumbled 39.16% in 2022 and jumped 301.37% in 2023.
• Over 5 years, Non-Current Assets stood at $13.1 million in 2022, then decreased by 14.45% to $11.2 million in 2023, then dropped by 10.91% to $10.0 million in 2024, then decreased by 13.5% to $8.7 million in 2025, then retreated by 8.38% to $7.9 million in 2026.
• Per Business Quant data, the three most recent Non-Current Assets figures were $7.9 million in Q2 2026, $8.7 million in Q4 2025, and $9.0 million in Q3 2025.